The pandemic of the disease COVID-19 (COronaVIrus Disease 2019) caused by the SARS-CoV-2 coronavirus (severe acute respiratory syndrome coronavirus 2) resulted in millions of deaths and many patients have chronic consequences after overcoming the acute condition. Several vaccines have been developed in an effort to stop the spread of the virus, but they have potentially serious adverse effects. We present a case report of a patient with acute (myocarditis, exacerbation of bronchial asthma) and long-term (postural orthostatic tachycardia syndrome - POTS) complications after vaccination with the second dose of mRNA vaccine BNT162b2 (Comirnaty®). Treatment consists of regimen measures, numerous pharmacotherapy (metoprolol, ivabradine, corticosteroids, antihistamines, antiphlogistics, bronchodilators) and several nutraceuticals (maritime pine bark extract, quercetin, vitamins, magnesium, phosphatidylcholine). In the discussion, we analyze post-vaccination injury and present a short review of the current literature.
Keyphrases
- respiratory syndrome coronavirus
- sars cov
- coronavirus disease
- liver failure
- respiratory failure
- chronic obstructive pulmonary disease
- end stage renal disease
- drug induced
- case report
- newly diagnosed
- ejection fraction
- systematic review
- chronic kidney disease
- oxidative stress
- aortic dissection
- heart rate
- binding protein
- lung function
- anti inflammatory
- hepatitis b virus
- blood pressure
- air pollution
- replacement therapy
- cystic fibrosis
- extracorporeal membrane oxygenation
- combination therapy